Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 2040798
PUBLISHER: Grand View Research | PRODUCT CODE: 2040798
U.S. Cath Labs Market Size, Share & Trends Analysis Report By Component (Services, Equipment, Medical Devices), By Facility Type (Independent, Hospital-based), Key Companies And Competitive Analysis And Segment Forecasts, 2026 - 2033
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
U.S. Cath Labs Market Summary
The U.S. cath labs market size was estimated at USD 16.8 billion in 2025 and is projected to reach USD 17.7 billion in 2033, growingat a CAGR of 5.5% from 2026 to 2033. The market is expected to grow significantly owing to the high incidence of cardiovascular diseases and the technological advancements in diagnostic techniques.
In addition, the growing expenditure on healthcare by the citizens and the initiatives by the federal government to increase awareness regarding cardiac health are increasing the growth opportunities for the market. Approximately 20.1 million residents in the U.S. above 20 years of age have coronary artery disease. 805,000 Americans have a heart attack annually. West Virginia has the highest prevalence of heart disorders in the U.S., with an age-weighted prevalence of 6.3% as per the CDC.
The section highlights the key factors driving the growth of the U.S. cath labs industry, including rising heart diseases, increasing adoption of new technologies, and growing emphasis on clinical excellence, among others.
U.S. Cath Labs Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. cath labs market report based on component, and facility type.
- Component Outlook (Revenue, USD Million, 2021 - 2033)
- Services
- Therapeutic
- Angioplasty
- Stent placement
- Rotational atherectomy
- Thrombectomy
- Cardioversion
- Transcatheter Aortic Valve Replacement (TAVR)
- Others
- Diagnostic
- Angiography
- Coronary intravascular ultrasound
- Cardiac catheterization
- ECG/EKG
- Fractional Flow Reserve (FFR)
- Others
- Equipment
- Imaging Equipment
- Angiography machines
- X-ray machines
- IVUS
- Monitors
- Procedure Room Equipment
- X-ray table
- Heart monitoring equipment
- Display screens
- Control Room Equipment
- Viewing monitor
- Hemodynamic monitoring system
- Other Equipment
- Infusion pumps
- Anesthetic and respiratory equipment
- Crash cart
- Medical Devices
- Stents
- Sheaths
- Guidewires
- Pacemakers
- Defibrillator
- CPR device
- Others
- Facility Type Outlook (Revenue, USD Million, 2021 - 2033)
- Independent Labs
- Hospital-Based Labs
Product Code: GVR-4-68039-160-4
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment Definitions
- 1.2. Estimates and Forecast Timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
- 1.4.6. Research Assumption
- 1.5. Information or Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Data Visualization
- 1.7. Model Details
- 1.7.1. Commodity Flow Analysis
- 1.8. Objectives
- 1.8.1. Objective - 1
- 1.8.2. Objective - 2
- 1.8.3. Objective - 3
- 1.9. List of Secondary Sources
- 1.10. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. U.S. Cath Labs Market
- 2.1.1. Market Snapshot
- 2.1.2. Segment Snapshot
- 2.1.2.1. Component segment outlook
- 2.1.2.2. Facility type segment outlook
- 2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.1.1. Rising incidence of cardiovascular disease
- 3.3.1.2. Low operational cost
- 3.3.1.3. Technological advancement
- 3.3.2. Market Restraint Analysis
- 3.3.2.1. Lack of reimbursement for independent lab
- 3.3.2.2. High maintenance cost for multispecialty labs
- 3.3.1. Market Driver Analysis
- 3.4. Regulatory Framework
- 3.5. Business Environment Analysis Tools
- 3.5.1. Industry Analysis - Porter's Five Forces Analysis
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.1. Industry Analysis - Porter's Five Forces Analysis
Chapter 4. Component Business Analysis
- 4.1. U.S. Cath Labs Market: Component Movement Analysis
- 4.2. U.S. Cath Labs Market: Component Segment Dashboard
- 4.3. Component Movement & Market Share Analysis, 2025 & 2033
- 4.4. U.S. Cath Labs Market Estimates & Forecast, by Component
- 4.5. Services
- 4.5.1. Services market, 2021 - 2033 (USD Million)
- 4.5.2. Therapeutics
- 4.5.2.1. Therapeutics market, 2021 - 2033 (USD Million)
- 4.5.2.2. Angioplasty market, 2021 - 2033 (USD Million)
- 4.5.2.2.1. Angioplasty market, 2021 - 2033 (USD Million)
- 4.5.2.3. Stent placement market, 2021 - 2033 (USD Million)
- 4.5.2.3.1. Stent placement market, 2021 - 2033 (USD Million)
- 4.5.2.4. Rotational atherectomy market, 2021 - 2033 (USD Million)
- 4.5.2.4.1. Rotational atherectomy market, 2021 - 2033 (USD Million)
- 4.5.2.5. Thrombectomy market, 2021 - 2033 (USD Million)
- 4.5.2.5.1. Thrombectomy market, 2021 - 2033 (USD Million)
- 4.5.2.6. Cardioversion market, 2021 - 2033 (USD Million)
- 4.5.2.6.1. Cardioversion market, 2021 - 2033 (USD Million)
- 4.5.2.7. Transcatheter Aortic Valve Replacement (TAVR) market, 2021 - 2033 (USD Million)
- 4.5.2.7.1. Transcatheter Aortic Valve Replacement (TAVR) market, 2021 - 2033 (USD Million)
- 4.5.2.8. Others market, 2021 - 2033 (USD Million)
- 4.5.2.8.1. Others market, 2021 - 2033 (USD Million)
- 4.5.3. Diagnostic
- 4.5.3.1. Diagnostic market, 2021 - 2033 (USD Million)
- 4.5.3.2. Angiography market, 2021 - 2033 (USD Million)
- 4.5.3.2.1. Angiography market, 2021 - 2033 (USD Million)
- 4.5.3.3. Coronary intravascular ultrasound market, 2021 - 2033 (USD Million)
- 4.5.3.3.1. Coronary intravascular ultrasound market, 2021 - 2033 (USD Million)
- 4.5.3.4. Cardiac catheterization market, 2021 - 2033 (USD Million)
- 4.5.3.4.1. Cardiac catheterization market, 2021 - 2033 (USD Million)
- 4.5.3.5. ECG/EKG market, 2021 - 2033 (USD Million)
- 4.5.3.5.1. ECG/EKG market, 2021 - 2033 (USD Million)
- 4.5.3.6. Fractional Flow Reserve (FFR) market, 2021 - 2033 (USD Million)
- 4.5.3.6.1. Fractional Flow Reserve (FFR) market, 2021 - 2033 (USD Million)
- 4.5.3.7. Others market, 2021 - 2033 (USD Million)
- 4.5.3.7.1. Others market, 2021 - 2033 (USD Million)
- 4.6. Equipment
- 4.6.1. Equipment market, 2021 - 2033 (USD Million)
- 4.6.2. Imaging Equipment
- 4.6.2.1. Imaging equipment market, 2021 - 2033 (USD Million)
- 4.6.2.2. X-ray machines market, 2021 - 2033 (USD Million)
- 4.6.2.2.1. X-ray machines market, 2021 - 2033 (USD Million)
- 4.6.2.3. Angiography machines market, 2021 - 2033 (USD Million)
- 4.6.2.3.1. Angiography machines market, 2021 - 2033 (USD Million)
- 4.6.2.4. IVUS market, 2021 - 2033 (USD Million)
- 4.6.2.4.1. IVUS market, 2021 - 2033 (USD Million)
- 4.6.3. Monitors
- 4.6.3.1.1. Monitors market, 2021 - 2033 (USD Million)
- 4.6.4. Procedure room equipment
- 4.6.4.1. Procedure room equipment market, 2021 - 2033 (USD Million)
- 4.6.4.2. X-ray table market, 2021 - 2033 (USD Million)
- 4.6.4.2.1. X-ray table market, 2021 - 2033 (USD Million)
- 4.6.4.3. Heart monitoring equipment market, 2021 - 2033 (USD Million)
- 4.6.4.3.1. Heart monitoring equipment market, 2021 - 2033 (USD Million)
- 4.6.4.4. Display screens market, 2021 - 2033 (USD Million)
- 4.6.4.4.1. Display screens market, 2021 - 2033 (USD Million)
- 4.6.5. Control room equipment
- 4.6.5.1. Control room equipment market, 2021 - 2033 (USD Million)
- 4.6.5.2. Viewing monitor market, 2021 - 2033 (USD Million)
- 4.6.5.2.1. Viewing monitor market, 2021 - 2033 (USD Million)
- 4.6.5.3. Hemodynamic monitoring system market, 2021 - 2033 (USD Million)
- 4.6.5.3.1. Hemodynamic monitoring system market, 2021 - 2033 (USD Million)
- 4.6.6. Other equipment
- 4.6.6.1. Other equipment market, 2021 - 2033 (USD Million)
- 4.6.6.2. Infusion pumps market, 2021 - 2033 (USD Million)
- 4.6.6.2.1. Infusion pumps market, 2021 - 2033 (USD Million)
- 4.6.6.3. Anesthetic and respiratory equipment market, 2021 - 2033 (USD Million)
- 4.6.6.3.1. Anesthetic and respiratory equipment market, 2021 - 2033 (USD Million)
- 4.6.6.4. Crash cart market, 2021 - 2033 (USD Million)
- 4.6.6.4.1. Crash cart market, 2021 - 2033 (USD Million)
- 4.7. Medical Devices
- 4.7.1. Medical devices market, 2021 - 2033 (USD Million)
- 4.7.2. Stents
- 4.7.2.1. Stents market, 2021 - 2033 (USD Million)
- 4.7.3. Sheaths
- 4.7.3.1. Sheaths market, 2021 - 2033 (USD Million)
- 4.7.4. Guidewires
- 4.7.4.1. Guidewires market, 2021 - 2033 (USD Million)
- 4.7.5. Pacemakers
- 4.7.5.1. Pacemakers market, 2021 - 2033 (USD Million)
- 4.7.6. Defibrillator
- 4.7.6.1. Defibrillator market, 2021 - 2033 (USD Million)
- 4.7.7. CPR device
- 4.7.7.1. CPR device market, 2021 - 2033 (USD Million)
- 4.7.8. Others
- 4.7.8.1. Others market, 2021 - 2033 (USD Million)
Chapter 5. Facility Type Business Analysis
- 5.1. U.S. Cath Labs Market: Facility Type Movement Analysis
- 5.2. U.S. Cath Labs Market: Facility Type Segment Dashboard
- 5.3. Facility type Movement & Market Share Analysis, 2025 & 2033
- 5.4. U.S. Cath Labs Market Estimates & Forecast, by Facility Type
- 5.5. Independent Labs
- 5.5.1. Independent labs market, 2021 - 2033 (USD Million)
- 5.6. Hospital-Based Labs
- 5.6.1. Hospital-based labs market, 2021 - 2033 (USD Million)
Chapter 6. Manufacturing Company Landscape
- 6.1. Company Categorization
- 6.2. Company Market Position Analysis
- 6.3. Company Share Analysis
- 6.4. Strategy Mapping
- 6.4.1. Partnership/Collaboration/Alliance
- 6.4.2. New Product Launch
- 6.4.3. Mergers & Acquisitions
- 6.4.4. Others
- 6.5. Company Profiles/Listing
- 6.5.1. Shockwave Medical
- 6.5.1.1. Overview
- 6.5.1.2. Financial performance
- 6.5.1.3. Product benchmarking
- 6.5.1.4. Strategic initiatives
- 6.5.2. Boston Scientific Corporation
- 6.5.2.1. Overview
- 6.5.2.2. Financial performance
- 6.5.2.3. Product benchmarking
- 6.5.2.4. Strategic initiatives
- 6.5.3. GE Healthcare
- 6.5.3.1. Overview
- 6.5.3.2. Financial performance
- 6.5.3.3. Product benchmarking
- 6.5.3.4. Strategic initiatives
- 6.5.4. Koninklijke Philips N.V.
- 6.5.4.1. Overview
- 6.5.4.2. Financial performance
- 6.5.4.3. Product benchmarking
- 6.5.4.4. Strategic initiatives
- 6.5.5. Siemens Healthineers
- 6.5.5.1. Overview
- 6.5.5.2. Financial performance
- 6.5.5.3. Product benchmarking
- 6.5.5.4. Strategic initiatives
- 6.5.6. Abbott Laboratories
- 6.5.6.1. Overview
- 6.5.6.2. Financial performance
- 6.5.6.3. Product benchmarking
- 6.5.6.4. Strategic initiatives
- 6.5.7. Stryker
- 6.5.7.1. Overview
- 6.5.7.2. Financial performance
- 6.5.7.3. Product benchmarking
- 6.5.7.4. Strategic initiatives
- 6.5.8. Cordis
- 6.5.8.1. Overview
- 6.5.8.2. Financial performance
- 6.5.8.3. Product benchmarking
- 6.5.8.4. Strategic initiatives
- 6.5.9. AngioDynamics
- 6.5.9.1. Overview
- 6.5.9.2. Financial performance
- 6.5.9.3. Product benchmarking
- 6.5.9.4. Strategic initiatives
- 6.5.10. Medtronic
- 6.5.10.1. Overview
- 6.5.10.2. Financial performance
- 6.5.10.3. Product benchmarking
- 6.5.10.4. Strategic initiatives
- 6.5.11. Shimadzu Corporation
- 6.5.11.1. Overview
- 6.5.11.2. Financial performance
- 6.5.11.3. Product benchmarking
- 6.5.11.4. Strategic initiatives
- 6.5.12. Johnson & Johnson
- 6.5.12.1. Overview
- 6.5.12.2. Financial performance
- 6.5.12.3. Product benchmarking
- 6.5.12.4. Strategic initiatives
- 6.5.13. B. Braun Melsungen AG
- 6.5.13.1. Overview
- 6.5.13.2. Financial performance
- 6.5.13.3. Product benchmarking
- 6.5.13.4. Strategic initiatives
- 6.5.14. Cardinal Health, Inc.
- 6.5.14.1. Overview
- 6.5.14.2. Financial performance
- 6.5.14.3. Product benchmarking
- 6.5.14.4. Strategic initiatives
- 6.5.1. Shockwave Medical
Chapter 7. Service Provider Company Landscape
- 7.1. Company Categorization
- 7.2. Company Market Position Analysis
- 7.3. Company Share Analysis
- 7.4. Strategy Mapping
- 7.4.1. Partnership/Collaboration/Alliance
- 7.4.2. New Service Launch
- 7.4.3. Mergers & Acquisitions
- 7.4.4. Others
- 7.5. Company Profiles/Listing
- 7.5.1. Cleveland Clinic
- 7.5.1.1. Overview
- 7.5.1.2. Financial performance
- 7.5.1.3. Service benchmarking
- 7.5.1.4. Strategic initiatives
- 7.5.2. Cedars-Sinai
- 7.5.2.1. Overview
- 7.5.2.2. Financial performance
- 7.5.2.3. Service benchmarking
- 7.5.2.4. Strategic initiatives
- 7.5.3. Mayo Clinic
- 7.5.3.1. Overview
- 7.5.3.2. Financial performance
- 7.5.3.3. Service benchmarking
- 7.5.3.4. Strategic initiatives
- 7.5.4. NewYork-Presbyterian Hospital
- 7.5.4.1. Overview
- 7.5.4.2. Financial performance
- 7.5.4.3. Service benchmarking
- 7.5.4.4. Strategic initiatives
- 7.5.5. Northwestern Medicine
- 7.5.5.1. Overview
- 7.5.5.2. Financial performance
- 7.5.5.3. Service benchmarking
- 7.5.5.4. Strategic initiatives
- 7.5.6. Stanford Health Care
- 7.5.6.1. Overview
- 7.5.6.2. Financial performance
- 7.5.6.3. Service benchmarking
- 7.5.6.4. Strategic initiatives
- 7.5.7. Houston Methodist
- 7.5.7.1. Overview
- 7.5.7.2. Financial performance
- 7.5.7.3. Service benchmarking
- 7.5.7.4. Strategic initiatives
- 7.5.1. Cleveland Clinic
Product Code: GVR-4-68039-160-4
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviations
- Table 3 U.S. skilled nursing facility market revenue estimates and forecast, by component, 2021 - 2033 (USD Million)
- Table 4 U.S. skilled nursing facility market revenue estimates and forecast, by facility type, 2021 - 2033 (USD Million)
List of Figures
- Fig. 1 US cath labs market segmentation
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value chain based sizing & forecasting
- Fig. 7 QFD modelling for market share assessment
- Fig. 8 Market formulation & validation
- Fig. 9 Market snapshot
- Fig. 10 Type segment outlook
- Fig. 11 Competitive landscape
- Fig. 12 US cath labs market: Market dynamics
- Fig. 13 US cath labs market: Porter's analysis
- Fig. 14 US cath labs market: PESTLE analysis
- Fig. 15 US cath labs market: Component segment dashboard
- Fig. 16 US cath labs market: Component movement share analysis
- Fig. 17 Services market, 2021 - 2033 (USD Million)
- Fig. 18 Therapeutic market, 2021 - 2033 (USD Million)
- Fig. 19 Angioplasty market, 2021 - 2033 (USD Million)
- Fig. 20 Stent placement market, 2021 - 2033 (USD Million)
- Fig. 21 Rotational atherectomy market, 2021 - 2033 (USD Million)
- Fig. 22 Thrombectomy market, 2021 - 2033 (USD Million)
- Fig. 23 Cardioversion market, 2021 - 2033 (USD Million)
- Fig. 24 Transcatheter Aortic Valve Replacement (TAVR) market, 2021 - 2033 (USD Million)
- Fig. 25 Others market, 2021 - 2033 (USD Million)
- Fig. 26 Diagnostic market, 2021 - 2033 (USD Million)
- Fig. 27 Angiography market, 2021 - 2033 (USD Million)
- Fig. 28 Coronary intravascular ultrasound market, 2021 - 2033 (USD Million)
- Fig. 29 Cardiac catheterization market, 2021 - 2033 (USD Million)
- Fig. 30 ECG/EKG market, 2021 - 2033 (USD Million)
- Fig. 31 Fractional Flow Reserve (FFR) market, 2021 - 2033 (USD Million)
- Fig. 32 Others market, 2021 - 2033 (USD Million)
- Fig. 33 Equipment market, 2021 - 2033 (USD Million)
- Fig. 34 Equipment market, 2021 - 2033 (USD Million)
- Fig. 35 Imaging equipment market, 2021 - 2033 (USD Million)
- Fig. 36 X-ray machines market, 2021 - 2033 (USD Million)
- Fig. 37 Angiography machines market, 2021 - 2033 (USD Million)
- Fig. 38 IVUS market, 2021 - 2033 (USD Million)
- Fig. 39 Monitors market, 2021 - 2033 (USD Million)
- Fig. 40 Procedure room equipment market, 2021 - 2033 (USD Million)
- Fig. 41 X-ray table market, 2021 - 2033 (USD Million)
- Fig. 42 Heart monitoring equipment market, 2021 - 2033 (USD Million)
- Fig. 43 Display screens market, 2021 - 2033 (USD Million)
- Fig. 44 Control room equipment market, 2021 - 2033 (USD Million)
- Fig. 45 Viewing monitor market, 2021 - 2033 (USD Million)
- Fig. 46 Hemodynamic monitoring system market, 2021 - 2033 (USD Million)
- Fig. 47 Medical devices market, 2021 - 2033 (USD Million)
- Fig. 48 Stents 2021 - 2033 (USD Million)
- Fig. 49 Sheaths 2021 - 2033 (USD Million)
- Fig. 50 Guidewires 2021 - 2033 (USD Million)
- Fig. 51 Pacemakers 2021 - 2033 (USD Million)
- Fig. 52 Defibrillator 2021 - 2033 (USD Million)
- Fig. 53 CPR device 2021 - 2033 (USD Million)
- Fig. 54 Others 2021 - 2033 (USD Million)
- Fig. 55 Other equipment market, 2021 - 2033 (USD Million)
- Fig. 56 Infusion pumps market, 2021 - 2033 (USD Million)
- Fig. 57 Anesthetic and respiratory equipment market, 2021 - 2033 (USD Million)
- Fig. 58 Crash cart market, 2021 - 2033 (USD Million)
- Fig. 59 US cath labs market: Facility type segment dashboard
- Fig. 60 US cath labs market: Facility type movement share analysis
- Fig. 61 Independent labs market, 2021 - 2033 (USD Million)
- Fig. 62 Hospital-based labs market, 2021 - 2033 (USD Million)
- Fig. 63 Company categorization
- Fig. 64 Company market position analysis, 2025
- Fig. 65 Strategic framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.